AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

Published: Nov 06, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 1:00 p.m. (ET) in New York City.

Back to news